Anchorage Capital Group, L.L.C.

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Anchorage Capital Group, L.L.C. reported 5 stock positions worth $258.7 million. Its top holding was Sentinelone Class A (S) at 34.9% of the portfolio, followed by Frontier Communications Pare (FYBR, 34.4%) and Roivant Sciences (ROIV, 21.1%). Its holdings were unchanged from Q1 2025.

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$258.7M (Q2 2025)
SEC Filing
0000905148-25-002932 ↗ filed Aug 14, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 5 stocks · $258.7M
S Sentinelone Inc. Class A 34.89% 4,937,053 $90.2M No change
FYBR Frontier Communications Pare 34.39% 2,443,742 $89.0M No change
ROIV Roivant Sciences Ltd. 21.06% 4,832,642 $54.5M No change
DNA Ginkgo Bioworks Holdings Inc. 7.60% 1,746,363 $19.6M No change
AMBP Ardagh Metal Packaging SA 2.07% 1,250,000 $5.3M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $37K (not counted above)
SecurityClassShares / PrincipalValueChange
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$37KNo change

Total filed on the 13F, all lines: $258.7M.

Portfolio Sells Q1 2025 → Q2 2025
None this quarter.

Portfolio Buys Q1 2025 → Q2 2025
None this quarter.

Notes & Other Activity Q1 2025 → Q2 2025
THE REALREAL INC (REAL 4 02/15/31) DEBT 4.000% 2/1 · principal Sold out 12,077,000 $10.2Mbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP